echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > $200 million transaction!

    $200 million transaction!

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    On October 12, Yehui Pharmaceutical announced that it had signed a licensing agreement with Sutro Biopharma.


    According to the agreement, Yehui Pharmaceutical can choose to obtain the exclusive right to develop and commercialize STRO-001 in Greater China


    Yehui Pharmaceuticals will pay Sutro a down payment of US$4 million, with potential payments related to option exercise, drug development, registration and commercial milestones totaling up to US$200 million


    CD74 is expressed in a variety of blood cancers, and the drug-antibody ratio of STRO-001 is 2


    In the United States, Sutro is exploring STRO-001 as a treatment for advanced patients with multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma, mantle cell lymphoma, and follicles Lymphoma


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.